Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Filing Details

Accession Number:
0001144204-18-014486
Form Type:
4
Zero Holdings:
No
Publication Time:
2018-03-13 22:00:09
Reporting Period:
2016-07-13
Accepted Time:
2018-03-13 22:00:09
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1551986 Innovate Biopharmaceuticals Inc. INNT () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1251818 H David Clarke 2655 First Street, Suite 250
Simi Valley CA 93065
Former Ceo And Director Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2016-07-13 15,000 $4.50 445,043 No 4 P Direct
Common Stock Acquisiton 2017-01-24 175,000 $0.00 620,043 No 4 A Direct
Common Stock Acquisiton 2017-03-16 70,000 $1.50 690,043 No 4 P Indirect See footnote
Common Stock Acquisiton 2017-06-23 172,414 $0.58 862,457 No 4 P Indirect See footnote
Common Stock Acquisiton 2017-06-30 33,621 $0.00 896,078 No 4 A Indirect See footnote
Common Stock Acquisiton 2017-06-30 13,467 $0.00 909,545 No 4 A Indirect See footnote
Common Stock Acquisiton 2017-11-09 100,000 $0.00 1,009,545 No 4 A Direct
Common Stock Acquisiton 2017-11-29 366,159 $0.45 1,375,704 No 4 P Indirect See footnote
Common Stock Acquisiton 2018-01-24 17,746 $0.00 1,393,450 No 4 A Indirect See footnote
Common Stock Acquisiton 2018-01-25 25,000 $0.00 1,418,450 No 4 A Direct
Common Stock Acquisiton 2018-01-26 300,000 $0.35 1,718,450 No 4 P Indirect See footnote
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
No 4 A Direct
No 4 P Indirect See footnote
No 4 P Indirect See footnote
No 4 A Indirect See footnote
No 4 A Indirect See footnote
No 4 A Direct
No 4 P Indirect See footnote
No 4 A Indirect See footnote
No 4 A Direct
No 4 P Indirect See footnote
Footnotes
  1. Shares of restricted common stock granted under Issuer's 2012 Omnibus Incentive Plan.
  2. Reporting Person's beneficial ownership includes: 71,402 shares of common stock held by his spouse and 1,063,350 shares of common stock held by GSB Holdings, Inc., a corporation owned by his spouse and children.